BRIEF published on 10/01/2024 at 00:56, 1 year 10 months ago Valerio Therapeutics Reports First Half 2024 Financial Results Financial Results R&D Clinical Trial Valerio Therapeutics Single Domain Antibodies
BRIEF published on 10/01/2024 at 00:45, 1 year 10 months ago Valerio Therapeutics Reports Half-Year 2024 Financial Results and Strategic Updates Financial Results Emglev Acquisition VIO-01 Clinical Trial PlatON™ Platform Therapeutic Innovations
PRESS RELEASE published on 10/01/2024 at 00:40, 1 year 10 months ago Inside Information: News release on accounts, results Valerio Therapeutics reports its half-year 2024 financial results and updates on its activities, including the acquisition of Emglev Therapeutics and progress on the VIO-01 trial Acquisition Financial Results Valerio Therapeutics VIO-01 Trial Emglev Therapeutics
PRESS RELEASE published on 09/30/2024 at 22:40, 1 year 10 months ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report
BRIEF published on 08/05/2024 at 19:23, 2 years ago Half-yearly review of the liquidity contract with Kepler Cheuvreux Liquidity Contract Transactions Kepler Cheuvreux AMF Valerio Therapeutics
PRESS RELEASE published on 08/05/2024 at 19:18, 2 years ago Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract Valerio Therapeutics releases half-year liquidity contract statement revealing shares and trading volumes Liquidity Contract Shares AMF Decision Valerio Therapeutics Trading Volumes
BRIEF published on 06/05/2024 at 07:05, 2 years 2 months ago Minutes of the general meeting of Valerio Therapeutics Biotechnology Voting Results General Meeting Resolutions Valerio Therapeutics
PRESS RELEASE published on 06/05/2024 at 07:00, 2 years 2 months ago Inside Information / Other news releases Valerio Therapeutics reports successful Combined General Meeting with 48.1% quorum, adopting all resolutions. Consolidated vote results and meeting minutes to be available on the Company's website Euronext Growth Paris Biotechnology General Meeting Valerio Therapeutics DDR Drugs
BRIEF published on 05/22/2024 at 20:51, 2 years 2 months ago Valerio Therapeutics Advances VIO-01 Clinical Trial with Positive Results Drug Development Solid Tumors Clinical Trial Valerio Therapeutics VIO-01
PRESS RELEASE published on 05/22/2024 at 20:46, 2 years 2 months ago Inside Information / Other news releases Valerio Therapeutics completes dosing for first cohort of subjects in Phase 1/2 VIO-01 trial for solid tumors, showing encouraging tolerability. Phase 1b aims to determine recommended dose in selected solid tumors Solid Tumors Valerio Therapeutics VIO-01 Trial Phase 1/2 DNA Damage Response
Published on 08/18/2026 at 19:45, 1 hour 39 minutes ago ECC Ventures 5 Corp. Enters Into Business Combination Agreement with Bayrock Resources for Qualifying Transaction
Published on 08/18/2026 at 18:30, 2 hours 54 minutes ago Sterling Metals Announces Approval of Arrangement by QcX Gold Shareholders
Published on 08/18/2026 at 17:40, 3 hours 44 minutes ago Largo Physical Vanadium Announces Postponement of Annual Meeting
Published on 08/18/2026 at 17:00, 4 hours 24 minutes ago Galaxy Ventures Inc.: TruSilver Deepens 1960s Holes to 712 Metres, Logs Sulphides Next to Past-Producing Walton Silver Mine
Published on 08/18/2026 at 15:30, 5 hours 54 minutes ago PPX Receives Environmental Approval for 10,315 metre Drill Program at Portachuelos, Igor Project
Published on 08/18/2026 at 19:00, 2 hours 24 minutes ago HIAG strengthens sustainable financing with third green bond worth CHF 100 million
Published on 08/18/2026 at 18:45, 2 hours 39 minutes ago Information about Mr. Svetlin Todorov‘s shareholdings in Shelly Group SE
Published on 08/18/2026 at 18:10, 3 hours 13 minutes ago Cumulus Neuroscience Announces Publication in Scientific Reports Demonstrating the NeuLogiq® Platform Is Feasible and Usable for At-Home, Multimodal Cognitive Assessment in People Living with ALS and FTD
Published on 08/18/2026 at 18:05, 3 hours 18 minutes ago Hi3D V3.0, the First Commercially Available AI 3D Model with 2048³ Voxel Resolution, Launches with 48 Hours of Free Access for Everyone
Published on 08/18/2026 at 17:30, 3 hours 53 minutes ago Lionsgate Play Selects NAGRAVISION to Protect Streaming Service
Published on 08/18/2026 at 11:15, 10 hours 8 minutes ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 1 day 1 hour ago Aéroports de Paris S.A - July 2026 traffic figures
Published on 08/17/2026 at 08:33, 1 day 12 hours ago Covivio - Information on Treasury shares transactions between August 10th, 2026 and August 11th, 2026
Published on 08/17/2026 at 07:30, 1 day 13 hours ago Disclosure of transactions in own shares from August 10 to August 14, 2026
